| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4295315 | Journal of the American College of Surgeons | 2006 | 10 Pages |
Abstract
OLT is a viable treatment option for primary HCC. LRT substantially downstages the primary tumor and improves longterm survival in patients with advanced disease. Complete tumor necrosis with LRT is associated with excellent longterm recurrence-free survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Ankit MD, Daniel B. MD, Jeffrey S. MD, Jennifer E. MD, Jeffrey A. MD, FACS, Surendra MD, PhD, Niraj M. MD, William C. MD, FACS,